1. Home
  2. RFL vs LLAP Comparison

RFL vs LLAP Comparison

Compare RFL & LLAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • LLAP
  • Stock Information
  • Founded
  • RFL 2017
  • LLAP 2013
  • Country
  • RFL United States
  • LLAP United States
  • Employees
  • RFL N/A
  • LLAP N/A
  • Industry
  • RFL Real Estate
  • LLAP Military/Government/Technical
  • Sector
  • RFL Finance
  • LLAP Industrials
  • Exchange
  • RFL Nasdaq
  • LLAP Nasdaq
  • Market Cap
  • RFL 48.4M
  • LLAP 50.3M
  • IPO Year
  • RFL N/A
  • LLAP N/A
  • Fundamental
  • Price
  • RFL $2.02
  • LLAP $0.25
  • Analyst Decision
  • RFL
  • LLAP Buy
  • Analyst Count
  • RFL 0
  • LLAP 3
  • Target Price
  • RFL N/A
  • LLAP $2.58
  • AVG Volume (30 Days)
  • RFL 47.3K
  • LLAP 5.5M
  • Earning Date
  • RFL 10-28-2024
  • LLAP 11-12-2024
  • Dividend Yield
  • RFL N/A
  • LLAP N/A
  • EPS Growth
  • RFL N/A
  • LLAP N/A
  • EPS
  • RFL N/A
  • LLAP N/A
  • Revenue
  • RFL $540,000.00
  • LLAP $133,107,000.00
  • Revenue This Year
  • RFL N/A
  • LLAP $8.71
  • Revenue Next Year
  • RFL N/A
  • LLAP $34.59
  • P/E Ratio
  • RFL N/A
  • LLAP N/A
  • Revenue Growth
  • RFL 92.86
  • LLAP 10.75
  • 52 Week Low
  • RFL $1.29
  • LLAP $0.23
  • 52 Week High
  • RFL $2.14
  • LLAP $1.62
  • Technical
  • Relative Strength Index (RSI)
  • RFL 75.57
  • LLAP 35.69
  • Support Level
  • RFL $1.65
  • LLAP $0.25
  • Resistance Level
  • RFL $1.94
  • LLAP $0.26
  • Average True Range (ATR)
  • RFL 0.10
  • LLAP 0.01
  • MACD
  • RFL 0.01
  • LLAP 0.01
  • Stochastic Oscillator
  • RFL 97.39
  • LLAP 24.64

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.

About LLAP Terran Orbital Corporation

Terran Orbital Corp is a manufacturer of satellite products primarily serving the aerospace and defense industries. The company provide end-to-end satellite solutions by combining satellite design, production, launch planning, mission operations, and on-orbit support to meet the needs of our military, civil, and commercial customers. Geographically company operates in United States and Europe. Majority of the revenue is generated from United States.

Share on Social Networks: